Lobe Sciences (CSE: LOBE) CEO Philip Young tells Proactive he's looking forward to presenting at Proactive's One2One Virtual Investor Forum on February 23, at 1pm EST.
Young says he hopes investors understand how the group has made the transition to a fully-integrated psychedelics company from a cannabis company. He expects to expand upon the group's final closure of divesting its cannabis business.